Liangliang Ji Profile
Liangliang Ji

@LiangliangJi

Followers
29
Following
32
Media
0
Statuses
10

Postdoc @MSKCancerCenter, PhD @IITU_Tsinghua, interested in #Macrophage, #Tumor #immunology, #Liver #metabolism, #Imaging, #Bioinformatics

Manhattan, NY
Joined November 2021
Don't wanna be here? Send us removal request.
@LiangliangJi
Liangliang Ji
2 years
How One Lab at MSK Is Working To Harness the Power of the Immune System Against Cancer
mskcc.org
Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.
0
0
4
@MingLiLab
Ming Li
2 years
Reprogram tumor-associated macrophages to outcompete endothelial progenitor cells and suppress tumor neoangiogenesis. Excited to share our new study @ImmunityCP by brilliant @miahdo1 , Wei Shi, and @CancerResearch fellow @LiangliangJi and collaborators!
Tweet media one
9
58
305
@MingLiLab
Ming Li
2 years
Reprogram tumor-associated macrophages to outmatch cancer cell competition. Excited to share our new study @Nature by brilliant @CancerResearch fellow @XianZhang2016 and collaborators! https://t.co/koxdb9Nmlr
Tweet media one
Tweet media two
14
109
446
@CellPressNews
Cell Press
2 years
Check out this perspective on nutrient acquisition and metabolism control of macrophage responses in tumor, a collaboration between @XianZhang2016 @LiangliangJi & @MingLiLab @ImmunityCP #ASCO23
0
18
58
@CancerResearch
Cancer Research Institute
3 years
How does nutrient metabolism regulate tumor-associated macrophages, and how can these processes be targeted for cancer therapy? CRI CLIP Investigator Dr. Ming Li @MingLiLab, and CRI Fellows Dr. Xian Zhang and Dr. Liangliang Ji @MSKCancerCenter review:
0
3
8
@MingLiLab
Ming Li
3 years
Glad to share a perspective on nutrient acquisition and metabolism control of macrophage responses in tumor @ImmunityCP with @CancerResearch fellows @XianZhang2016 @LiangliangJi
0
19
63
@MingLiLab
Ming Li
3 years
Glad to share a holistic immuno-oncology perspective through the lens of #TGFb @NatRevImmunol with implication for preclinical model choice for drug testing https://t.co/ZKegGVtyvq
Tweet media one
0
41
135